Norway
Tuberculosis profile
Population  2012 5 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.14 (0.14–0.14)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0–0.01)
Prevalence  (includes HIV+TB) 0.51 (0.22–0.94) 10 (4.3–19)
Incidence  (includes HIV+TB) 0.37 (0.33–0.42) 7.5 (6.6–8.5)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.04 (0.04–0.05)
Case detection, all forms (%) 92 (81–100)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 61 (19) Relapse    
Smear-negative 50 (15) Treatment after failure    
Smear-unknown / not done 90 (27) Treatment after default    
Extrapulmonary 128 (39) Other 35 (100)
Other 0 (0)      
Total new 329   Total retreatment 35  
           
Other (history unknown) 14        
Total new and relapse 329   Total cases notified 378  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.6 1.2 0.7
Age < 15 1 10 7
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 84   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 90  
Retreatment 79  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients 3  
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.3 (0.27–3.8) 0 (0–15)
MDR-TB cases among notified pulmonary
TB cases
3 (1–8) 0 (0–5)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 250 (99%) 19 (54%) 281
Laboratory-confirmed MDR-TB cases 3 2 6
Patients started on MDR-TB treatment     6
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-19 Data: www.who.int/tb/data